Viewing nowCombinationOrosartan Tablet 10/160 mg
Valsartan 160mg · Amlodipine Orotate 13.82mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.

MFDS item code 201308524 · Approved 2013.07.30 · Insurance code 642506970
Treatment of essential hypertension not adequately controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan. It effectively lowers blood pressure and helps reduce the risk of cardiovascular diseases. This treatment is suitable for patients who have difficulty managing their blood pressure and contributes to maintaining health by improving blood pressure control.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction or cholestasis. Patients aged 65 years or older: Caution should be exercised when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in people with an allergy to the active ingredients or dihydropyridine derivatives, women who are pregnant or breastfeeding, or patients with severe renal or liver dysfunction. Patients with a deficiency of sodium or body fluids may experience hypotension, so it is important to verify the condition before taking this medication and to take appropriate action immediately if symptoms of hypotension occur during treatment. Patients with high potassium levels should be cautious when taking this medication along with potassium supplements or other drugs that can increase potassium, and they should regularly monitor blood potassium levels. Patients with vascular problems in the kidneys or kidney transplant patients should be cautious when taking this medication as it may worsen kidney function. If symptoms of angioedema occur, treatment should be discontinued immediately and should not be resumed. Patients with heart failure or myocardial infarction should closely monitor kidney function and blood pressure changes when taking this medication. This medication has not been proven safe and effective for children, and is not recommended for this population. Older adults may take the same dosage as the general adult population, but should consult a physician if any unusual symptoms occur during treatment. Caution should be exercised when driving or operating machinery as dizziness or fatigue may occur. In cases of overdose, severe hypotension or arrhythmias may occur, so it is important to avoid exceeding the recommended dosage. This medication may interact with other antihypertensives, diuretics, potassium supplements, certain anti-inflammatory drugs, and lithium preparations; therefore, it is essential to inform the physician or pharmacist about any concurrent medications. Women planning to become pregnant should consult with healthcare professionals before taking this medication and should avoid it during pregnancy. Women who are breastfeeding should avoid this medication, and should consult healthcare professionals if unavoidable.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, position-dependent dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, itching, joint swelling, low back pain, arthritis, muscle cramps, fatigue, urinary frequency, polyuria, erectile dysfunction, edema, localized edema, facial edema, peripheral edema, tiredness, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, including serum sickness-hypersensitivity, increased serum potassium, vasculitis, elevated liver function tests, angioedema, vesicular dermatitis, myalgia, renal failure, kidney injury, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory disturbances, dysgeusia, peripheral neuropathy, hypertonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, neuralgia, sensory disturbances, Stevens-Johnson syndrome
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advised to maintain storage temperatures between 1 to 30 degrees Celsius at room temperature.
Bright yellow oval film-coated tablets
30 tablets/PTP, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Orotate 13.82mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
CombinationValsartan 80mg · Amlodipine Orotate 6.91mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
CombinationValsartan 160mg · Amlodipine Orotate 6.91mg
Tablet · Prescription medication · Combination
Dong-A ST Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.